KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena Inc., a leader in the discovery of G-protein coupled receptor (GPCR) biased ligands, announced today that it has named David Soergel, M.D. vice president and head, clinical development. In this role, Dr. Soergel is responsible for shaping Trevena’s clinical strategy and the operational execution of its development programs.
